MARSHALL WACE, LLP - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 63 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$1,897,000
-78.0%
222,095
-48.5%
0.02%
-48.6%
Q3 2018$8,632,000
+1326.8%
431,178
+1919.8%
0.04%
+516.7%
Q4 2015$605,000
-47.5%
21,348
-69.0%
0.01%
-57.1%
Q3 2015$1,153,000
-29.7%
68,848
+10.1%
0.01%
-33.3%
Q2 2015$1,639,000
-19.1%
62,521
-46.0%
0.02%
-19.2%
Q1 2015$2,027,000115,8830.03%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,423,578$8,826,0006.08%
Healthcare Value Capital, LLC 200,000$1,240,0002.33%
ARMISTICE CAPITAL, LLC 2,700,000$16,740,0001.06%
DELTEC ASSET MANAGEMENT LLC 550,836$3,415,0000.75%
Broadfin Capital, LLC 441,088$2,735,0000.60%
Kerrisdale Advisers, LLC 229,347$1,422,0000.51%
Worth Venture Partners, LLC 87,908$545,0000.30%
Mosaic Family Wealth, LLC 91,314$566,0000.24%
EMERALD ADVISERS, LLC 700,176$4,341,0000.17%
EMERALD MUTUAL FUND ADVISERS TRUST 616,664$3,823,0000.15%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders